Seres Therapeutics Statistics
Total Valuation
MCRB has a market cap or net worth of $26.92 million. The enterprise value is $67.97 million.
| Market Cap | 26.92M |
| Enterprise Value | 67.97M |
Important Dates
The next estimated earnings date is Wednesday, November 4, 2026, before market open.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MCRB has 10.04 million shares outstanding. The number of shares has increased by 10.80% in one year.
| Current Share Class | 10.04M |
| Shares Outstanding | 10.04M |
| Shares Change (YoY) | +10.80% |
| Shares Change (QoQ) | +1.29% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 9.40% |
| Float | 8.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.30 |
| Forward PS | n/a |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.78 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 36.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 1.64.
| Current Ratio | 2.11 |
| Quick Ratio | 2.04 |
| Debt / Equity | 1.64 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.57% and return on invested capital (ROIC) is -46.22%.
| Return on Equity (ROE) | -66.57% |
| Return on Assets (ROA) | -39.85% |
| Return on Invested Capital (ROIC) | -46.22% |
| Return on Capital Employed (ROCE) | -95.92% |
| Weighted Average Cost of Capital (WACC) | 1.92% |
| Revenue Per Employee | $28,530 |
| Profits Per Employee | -$340,348 |
| Employee Count | 66 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -85.98% in the last 52 weeks. The beta is 0.31, so MCRB's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -85.98% |
| 50-Day Moving Average | 4.34 |
| 200-Day Moving Average | 8.03 |
| Relative Strength Index (RSI) | 21.74 |
| Average Volume (20 Days) | 80,729 |
Short Selling Information
The latest short interest is 314,264, so 3.13% of the outstanding shares have been sold short.
| Short Interest | 314,264 |
| Short Previous Month | 301,344 |
| Short % of Shares Out | 3.13% |
| Short % of Float | 3.56% |
| Short Ratio (days to cover) | 5.53 |
Income Statement
In the last 12 months, MCRB had revenue of $1.88 million and -$22.46 million in losses. Loss per share was -$2.41.
| Revenue | 1.88M |
| Gross Profit | -46.08M |
| Operating Income | -78.23M |
| Pretax Income | -22.46M |
| Net Income | -22.46M |
| EBITDA | -74.78M |
| EBIT | -78.23M |
| Loss Per Share | -$2.41 |
Balance Sheet
The company has $15.59 million in cash and $56.64 million in debt, with a net cash position of -$41.05 million or -$4.09 per share.
| Cash & Cash Equivalents | 15.59M |
| Total Debt | 56.64M |
| Net Cash | -41.05M |
| Net Cash Per Share | -$4.09 |
| Equity (Book Value) | 34.53M |
| Book Value Per Share | 3.51 |
| Working Capital | 22.32M |
Cash Flow
In the last 12 months, operating cash flow was -$51.26 million and capital expenditures -$37,000, giving a free cash flow of -$51.30 million.
| Operating Cash Flow | -51.26M |
| Capital Expenditures | -37,000 |
| Depreciation & Amortization | 3.45M |
| Net Borrowing | n/a |
| Free Cash Flow | -51.30M |
| FCF Per Share | -$5.11 |
Margins
| Gross Margin | n/a |
| Operating Margin | -4,154.38% |
| Pretax Margin | -1,192.94% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MCRB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -10.80% |
| Shareholder Yield | -10.80% |
| Earnings Yield | -83.44% |
| FCF Yield | -190.55% |
Analyst Forecast
The average price target for MCRB is $17.00, which is 534.33% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $17.00 |
| Price Target Difference | 534.33% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | -23.16% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 22, 2025. It was a reverse split with a ratio of 1:20.
| Last Split Date | Apr 22, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
MCRB has an Altman Z-Score of -14.8 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -14.8 |
| Piotroski F-Score | 1 |